Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

OXYBUTYNIN 5 MG/5 ML SYRUP

Oxybutynin Chloride
$0.0321per ML

Strength

5 mg/5mL

Manufacturer

Lannett Company Inc.

NDC

54838051080

Classification

Generic

Dosage Form

SYRUP

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

OXYBUTYNIN CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA074520

On Market Since

3/29/1996

Pharmacological Classes

Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists

Price History

1W

0.0%

1M

-1.0%

3M

-1.7%

6M

-0.1%

1Y

-1.7%

3Y

-3.9%

5Y

+5.9%

All

+91.0%

Generic Alternatives

1 alternative • Same active ingredient

OXYBUTYNIN 5 MG/5 ML SOLUTION
Generic
62135052047•Chartwell RX LLC
$0.0321

Related Drugs

Same classification

OXYBUTYNIN 5 MG TABLET
Generic
52817026010•TruPharma LLC
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
52817026050•TruPharma LLC
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
64380016201•Strides Pharma Inc.
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
64380016202•Strides Pharma Inc.
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
64380016203•Strides Pharma Inc.
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
64980043101•Rising Pharma Holdings Inc.
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
64980043110•Rising Pharma Holdings Inc.
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
64980043150•Rising Pharma Holdings Inc.
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
69315018201•Leading Pharma, LLC
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
69315018205•Leading Pharma, LLC
$0.0484
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy